COMMUNIQUÉS West-GlobeNewswire

Bavarian Nordic Announces Initiation of Phase 2 Trial Evaluating the Combination Therapy of CV301 and Atezolizumab in Bladder Cancer
18/09/2018
Bavarian Nordic-sponsored study has commenced dosing Study marks the second of three planned Phase 2 combination studies of CV301 with checkpoint inhibitors in solid tumors COPENHAGEN, Denmark, September 18, 2018 - [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
18/09/2018
Company Announcement Copenhagen, Denmark; September 18, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 18,414 shares as a consequence of the exercise of employee warrants. The increase is [...]
UPDATE: Gala Pharmaceutical to Form Strategic Alliances to Boost Demand for Cannabis Testing Facilities
18/09/2018
IRVINE, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Gala Pharmaceutical, Inc. (Ticker: GLPH), an emerging cannabis testing company, today announced it expects to form strategic alliances with GreenGro Technologies ( [...]
SPINEWAY : Compte-rendu de l'Assemblée Générale du 13 septembre 2018
18/09/2018
Communiqué de presse Ecully, le 18 septembre 2018 Compte-rendu de l'Assemblée Générale L'Assemblée Générale Mixte des actionnaires de Spineway, spécialiste des implants et ancillaires chirurgicaux pour le traitement des [...]
Marrone Bio Innovations Announces Distribution Partnership with Hop Tri Investment Corporation in Vietnam
18/09/2018
Regalia ® , Grandevo ® and Majestene ® to Offer Vietnamese Growers Effective Biological Solutions as Regional Chemical Pesticide Reduction Begins DAVIS, Calif., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations [...]
Radient Technologies Inc. Unaware of Any Material Change
18/09/2018
EDMONTON, Alberta, Sept. 18, 2018 (GLOBE NEWSWIRE) -- At the request of IIROC, Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI ) wishes to confirm that the Company’s management is unaware of [...]
Elite Pharmaceuticals Files ANDA for Codeine and Acetaminophen Combo
18/09/2018
NORTHVALE, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]
Valeria Robinson-Baker, B.S.Pharm., R.Ph., C.Ph., is Appointed to the American Health Council’s Industry Board
18/09/2018
NEW YORK, Sept. 18, 2018 (GLOBE NEWSWIRE) -- The American Health Council appoints Valeria Robinson-Baker, B.S.Pharm., R.Ph., C.Ph., to its Industry Board. A supervisor of the Non-Sterile Compounding and Hazardous Drugs [...]
Foamix Announces Closing of its Follow-on Offering of Ordinary Shares and Full Exercise of its Option by the Underwriters
18/09/2018
REHOVOT, Israel, and BRIDGEWATER, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (“Foamix”) (Nasdaq: FOMX), a clinical-stage specialty pharmaceutical company focused on developing and [...]
Medtronic Announces Clinical Study of Transcatheter Aortic Valve Replacement in Aortic Stenosis Patients with Bicuspid Valves
18/09/2018
Medtronic Receives FDA Approval for Revised TAVR Labeling and Begins Investigational Study of Low Risk Patients with Bicuspid Valves DUBLIN - September 18, 2018 - Medtronic plc (NYSE:MDT) today announced that the U.S. [...]
Emblem and Canntab to Commence Clinical Testing of 12-Hour Extended Release Cannabis Tablets
18/09/2018
TORONTO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, a licensed producer of medical cannabis [...]
NewLink Genetics to Participate in the Cantor Global Healthcare Conference
18/09/2018
AMES, Iowa, Sept. 18, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced today that the Company will present at the 2018 Cantor Global Healthcare Conference on Wednesday, October 3, 2018, at 4 [...]
PHM Announces Accretive Acquisition of Respiratory Services Focused Business
18/09/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Protech Home [...]
Phoenix Life Sciences International Completes Merger and Announces Global Production Strategy
18/09/2018
DENVER, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Phoenix Life Sciences International Limited (“Phoenix Life”), an adaptive healthcare solutions company, today announced its common stock is now publicly traded in the United [...]
Q-Apps Now Listed in the Epic App Orchard to Achieve Easier Data Interoperability
18/09/2018
App Orchard process streamlines access to health record information that significantly increases efficiency and value of Q-Centrix quality solutions for hospitals and health systems. Chicago, Sept. 18, 2018 (GLOBE [...]
ContraVir Pharmaceuticals Announces Completion of Phase 1 with CRV431
18/09/2018
EDISON, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]
BioAegis Therapeutics Enrolls First Patients in Phase 1b/2a Community-Acquired Pneumonia Study and Raises $4 MM in Equity Round
18/09/2018
MORRISTOWN, N.J., Sept. 18, 2018 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc. announced that it has begun patient enrollment in a Phase 1b/2a study of recombinant plasma gelsolin (rhu-pGSN) in Community-Acquired [...]
Acasti Pharma Provides Clinical and Market Update
18/09/2018
TRILOGY phase 3 studies exceed 75% enrollment; on track to report topline results in 2019 LAVAL, Quebec, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator [...]
CBT Pharmaceuticals Initiates the APOLLO Oncology Clinical Trials Program
18/09/2018
First Patient Dosed in Initial Immunotherapy Combination Trial Utilizing CBT’s Proprietary Assets PLEASANTON, Calif. and HANGZHOU, China, Sept. 18, 2018 (GLOBE NEWSWIRE) -- CBT Pharmaceuticals (CBT), a U.S. and China- [...]

Pages